BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)
CUSIP: 07782B104
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Ordinary Shares, par value US$0.0001 per share
- Shares outstanding
- 37,379,062
- Total 13F shares
- 1,040,502
- Share change
- +190,317
- Total reported value
- $14,866,363
- Price per share
- $14.29
- Number of holders
- 6
- Value change
- +$2,374,158
- Number of buys
- 4
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07782B104:
Top shareholders of BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atria Wealth Solutions, Inc. |
13F
|
Company |
2.2%
|
812,098
|
$24,281,649 | — | 31 Mar 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.04%
|
15,786
|
$458,268 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
12,464
|
$361,830 | — | 31 Mar 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
7,528
|
$218,538 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
1,057
|
$31,604 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,038
|
$31,036 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
120
|
$3,588 | — | 31 Mar 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
94
|
$3,000 | — | 31 Mar 2023 |
Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q2 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.